Welcome to Vista
Bridging Research and Practice to Improve Clinical Care
Dedicated to Advancing Research on Alcohol and Drugs and Improving Behavioral Health Care for Young People
Let's make a difference, together.
〰️
Click here to join a Vista clinical trial.
〰️
Let's make a difference, together. 〰️ Click here to join a Vista clinical trial. 〰️
Our Mission
Our mission is to support innovative research and advance clinical care to confront this mounting drug crisis and discover new ways to help individuals and families improve their health and wellness.
Get news and updates in your inbox.
Sign up with your email to receive news about the latest research findings, our newly funded research projects, and practical guidance for people looking to reduce their substance use, parents, teachers and school administrators, and health care professionals.
Reimagining the Integration of Science and Practice
As clinicians and scientists, we know firsthand the day-to-day challenges we face in the clinical management of alcohol and other drug problems in youth along with the shortcomings of the best available therapies. We are committed to translating the latest scientific discoveries to advance clinical care.
What We Do
We conduct research and offer services to help young people take control of their alcohol and other drug use.
Innovating Through Research
Funded by the National Institutes of Health, our research initiatives leverage innovative technologies and the latest scientific knowledge in behavioral and biomedical sciences to uncover what drives addiction and develop new intervention strategies.
Advancing Clinical Care
In partnership with Bradley Hospital, we are at the forefront of transforming behavioral health care for teens and young adults by applying the latest research discoveries to optimize service delivery and support sustainable treatment outcomes.
Supporting Communities
Engaging and supporting communities, schools, and others who strive to help confront our worsening drug crisis and safeguard young people are essential to our mission.
In the news
-
![]()
Dr. Wycoff receives a highly competitive early-career research grant from the National Institutes of Health.
October 2024
Dr. Andrea Wycoff received a 5-year grant from the National Institute on Alcohol Abuse and Alcoholism to enhance treatment for teenagers dealing with alcohol and marijuana-related issues.
-
![]()
Dr. Miranda was invited to conduct advanced training on adolescent substance use at Rhode Island Student Assistance Services.
September 2024
Rhode Island Student Assistance Services (RISAS) provides evidence-based programs in schools and communities to prevent substance use and promote mental health.
-
![]()
Dr. Cristello accepted into NIH-supported program to enhance health equity in justice-involved youth.
August 2024
We are thrilled to announce that Dr. Cristello, our esteemed colleague, has been accepted into the prestigious Criminal Justice Research Training program.
The program, funded by the National Institute on Drug Abuse, brings together scholars from diverse backgrounds and research interests to enhance health equity within justice-involved populations.
-
![]()
Dr. Rosales receives a competitive fellowship award from eIRTI.
April 2022
Dr. Robert Rosales receiving a fellowship award from the Enhanced Interdisciplinary Research Training Institute on Hispanic Substance Abuse (eIRTI) at the University of Southern California.
-
![]()
TIME magazine interviews Dr. Miranda about teen drug use.
March 2022
TIME magazine interviews Dr. Robert Miranda about teen drug use and its depiction in the HBO series, Euphoria.
“What Euphoria Gets Right -and Wrong- About Teen Drug Use and Addiction” Read more.
-
![]()
Dr. Carpenter receives an early-career development award from the NIH.
March 2022
Dr. Ryan Carpenter receives an award from the National Institute on Alcohol Abuse and Alcoholism to advance treatment options for people who struggle with both alcohol and opioid problems.
-
![]()
Dr. Mereish receives prestigious early-career award .
June 2024
Congratulations to Dr. Ethan Mereish, who was honored to receive the 36th Annual Early Career Investigator Award from the Research Society on Alcohol, the world’s largest scientific research organization devoted to understanding the causes and complications of alcohol use and alcohol-related problems and to promoting effective strategies for prevention, intervention, and sustained behavior change!
-
![]()
Dr. Pielech is selected to co-chair national committee focused on youth.
August 2021
Dr. Melissa Pielech is selected to co-chair the Intervention Committee of the Adolescent and Young Adult Special Interest Group through the Society of Pediatric Psychology, Division 54 of the American Psychological Association.
-
![]()
Dr. Parnes receives an individual fellowship award from the NIH.
August 2021
Dr. Jamie Parnes receives a fellowship award (F32) from the NIH to study treatment effects, mechanisms, and moderators in youth cannabis use treatment. The award funded by the NIH National Institute on Drug Abuse and sponsored by Bradley Hospital and Brown University.
-
![]()
Dr. Pielech receives a supplemental award from the National Institute on Drug Abuse.
September 2024
Dr. Melissa Pielech secured supplementary support from the National Institute on Drug Abuse to adapt and integrate evidence-based brief interventions for teen substance use and pain into a groundbreaking, pre-surgical brief intervention designed for teens undergoing wisdom tooth extraction and their caregivers.
-
![]()
Dr. Rosales receives an early-career development award from the NIH.
June 2021
Dr. Robert Rosales receives an award from the National Institute on Minority Health and Health Disparities to study socio-cultural protective and risk factors of alcohol use among non-Hispanic White and Hispanic sexual minority youth.
-
![]()
Bradley Vista named a model treatment program for adolescents.
February 2021
Just 3 years after its launch, Bradley Vista receives national recognition from the Substance Abuse and Mental Health Services Administration as one of five model programs in the United States for treating youth who struggle with substance use and mental health issues.
Featured Projects
Let’s end addiction. Our featured projects represent our ongoing efforts to continue advancing treatments for individuals who struggle to reduce their alcohol and other drug use.
-
Principal Investigator: Robert Miranda Jr.
This study examines the effects of atomoxetine, an FDA-approved non-stimulant medication for treating ADHD, on alcohol use in youth. Participants take the study medication for 6 weeks and receive a computerized alcohol education program. We are looking for individuals ages 14-19 who are interested in reducing their alcohol use. Youth receive over $500 for their participation.
Support: National Institutes of Health (AA026326)
-
Principal Investigator: Robert Miranda Jr.
This study examines lamotrigine, a medicine already approved by the FDA to treat other conditions in children, teens, and adults, on alcohol use in youth. Participants take the study medication for 9 weeks and receive a computerized alcohol education program. We are looking for individuals ages 16-19 who are interested in reducing their alcohol use. Youth receive over $500 for their participation
Support: National Institutes of Health (AA028394)
-
Principal Investigator: Robert Miranda Jr.
In collaboration with the National Institute on Alcohol Abuse and Alcoholism, this project will test the effects of a new medication on alcohol craving and use in adults. Participants take the study medication for 6 weeks and receive a computerized alcohol education program. We will be looking for individuals ages 21 and older who are interested in reducing their drinking. Individuals can earn up to $595.
Support: National Institutes of Health (75N94021D00004)
